Recursion Pharmaceuticals-a(RXRX)
$9.51
Market is closed - opens 7 PM, 17 May 2024
Insights
- Recursion Pharmaceuticals-a is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Recursion Pharmaceuticals-a stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Recursion Pharmaceuticals-a stock is Range bound.
- Based on analysis of the Pivot Points, the current market trend for Recursion Pharmaceuticals-a stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 57.33 | Neutral |
Stochastic | 60.65, 74.05 | Neutral |
Ultimate Oscillator | 39.35 | Neutral |
Stochastic Relative Strength Index | 88.76, 93.21 | Sell |
Moving Average Convergence Divergence | 0.18, -0.06 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.15 | Buy |
20 | 8.56 | Sell |
50 | 9.23 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.21 | Buy |
20 | 8.94 | Sell |
50 | 9.25 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.45 | Neutral |
20 | 8.8 | Buy |
50 | 9.58 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.68 | Buy |
20 | 9.07 | Buy |
50 | 8.6 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.89 | Buy |
20 | 9.62 | Buy |
50 | 8.34 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 11.54 |
Resistance L2 | 11.1 |
Resistance L1 | 10.56 |
Pivot Point | 10.12 |
Support L1 | 9.57 |
Support L2 | 9.13 |
Support L3 | 8.59 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.